Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Schizophrenia

Free Subscription Articles published in Br J Psychiatry Retrieve available abstracts of 65 articles: HTML format

Single Articles

January 2026
1. CORBEIL O, Montalvo I, Labad J, Luykx JJ, et al
   Real-world studies in psychiatry: insights into antipsychotic-associated breast cancer risk and their broader implications.
   Br J Psychiatry. 2026;228:7-9.
   PubMed     Abstract available
   
   
   December 2025
2. FERNANDEZ-EGEA E
   Clozapine clinics at the crossroads and the opportunity to redesign services for people with chronic schizophrenia.
   Br J Psychiatry. 2025 Dec 18:1-2. doi: 10.1192/bjp.2025.10513.
   PubMed     Abstract available
   
   
   
3. ALEMAN-MORILLO C, Garcia-San-Martin N, Bethlehem RAI, Dorfschmidt L, et al
   Medication and atypical brain maturation in psychosis associated with long-term cognitive decline and symptom progression.
   Br J Psychiatry. 2025 Dec 11:1-11. doi: 10.1192/bjp.2025.10482.
   PubMed     Abstract available
   
   
   November 2025
4. AFE T, Ogunsemi O
   Revisiting Lambo's pioneering work: the role of cultural factors in paranoid psychosis among the Yoruba tribe - 70-year old perspective: commentary, Afe and Ogunsemi.
   Br J Psychiatry. 2025 Nov 24:1-2. doi: 10.1192/bjp.2025.10487.
   PubMed     Abstract available
   
   
   
5. DIEDERICH F, Oloyede E, Taylor D, Bachmann CJ, et al
   Economic evaluation of different haematological monitoring schemes for patients with treatment-resistant schizophrenia using clozapine.
   Br J Psychiatry. 2025 Nov 13:1-8. doi: 10.1192/bjp.2025.10424.
   PubMed     Abstract available
   
   
   
6. HOWES O, Kapi M, Bukala BR
   Does relapse matter? Insights from new data in schizophrenia.
   Br J Psychiatry. 2025 Nov 10:1-3. doi: 10.1192/bjp.2025.10470.
   PubMed     Abstract available
   
   
   October 2025
7. LIU W, Wang C, Guo F, Guo M, et al
   Structural connectivity of striatal subregions in first-episode schizophrenia: links to positive symptoms and treatment response.
   Br J Psychiatry. 2025 Oct 24:1-8. doi: 10.1192/bjp.2025.10434.
   PubMed     Abstract available
   
   
   
8. PEI H, Jiang S, Hou C, Li H, et al
   Accelerated ageing unfolds along the sensorimotor-association cortical axis in schizophrenia: multi-site study.
   Br J Psychiatry. 2025 Oct 1:1-9. doi: 10.1192/bjp.2025.10364.
   PubMed     Abstract available
   
   
   September 2025
9. PATEL R
   Cannabis and psychosis: minimising harm while maximising therapeutic potential.
   Br J Psychiatry. 2025 Sep 11:1-2. doi: 10.1192/bjp.2025.10389.
   PubMed     Abstract available
   
   
   
10. MONCRIEFF J, Priebe S
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders: commentary, Moncrieff et al.
    Br J Psychiatry. 2025 Sep 8:1-2. doi: 10.1192/bjp.2025.
    PubMed    
    
    
    
11. WILKINSON H, Johns LC, Batchelor R, Lau-Zhu A, et al
    Cognitive behavioural therapy for sleep problems in psychosis: systematic review of effectiveness and acceptability - CORRIGENDUM.
    Br J Psychiatry. 2025 Sep 4:1. doi: 10.1192/bjp.2025.10420.
    PubMed    
    
    
    
12. PRIES LK, Prachason T, Arias-Magnasco A, Lin BD, et al
    Impact of puberty timing, status and oestradiol on psychotic experiences in the context of exposomic and genomic vulnerability to schizophrenia in female adolescents: longitudinal ABCD study.
    Br J Psychiatry. 2025 Sep 3:1-8. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    August 2025
13. DE PERI L, Mellacqua ZB
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders: commentary, De Peri et al.
    Br J Psychiatry. 2025 Aug 19:1. doi: 10.1192/bjp.2025.10370.
    PubMed    
    
    
    July 2025
14. KISELY S, Bull C, Newton-Howes G, Zirnsak T, et al
    Restricting community treatment orders to people with non-affective psychosis is needed to reduce use and improve subsequent outcomes: Queensland-wide cohort study.
    Br J Psychiatry. 2025 Jul 23:1-6. doi: 10.1192/bjp.2025.10317.
    PubMed     Abstract available
    
    
    
15. HASHIMOTO K
    Host microbiota in clozapine-induced ileus and pneumonia among people with schizophrenia.
    Br J Psychiatry. 2025 Jul 22:1-2. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    
16. TREW A, Rodda J, Shergill SS
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders.
    Br J Psychiatry. 2025 Jul 21:1-2. doi: 10.1192/bjp.2025.
    PubMed    
    
    
    
17. ZHOU H, Luo H, Tang JY, Honer WG, et al
    Population-based study of long-term mortality risk associated with clozapine use among patients with schizophrenia.
    Br J Psychiatry. 2025 Jul 4:1-9. doi: 10.1192/bjp.2025.10312.
    PubMed     Abstract available
    
    
    June 2025
18. WILLIAMS R, Penington E, Gupta V, Quirk A, et al
    Critical components of 'Early Intervention in Psychosis': national retrospective cohort study.
    Br J Psychiatry. 2025 Jun 26:1-9. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
19. REILLY TJ, Chesney E, Al-Diwani A, Jewell A, et al
    Identification of menstrual psychosis cases using electronic health records.
    Br J Psychiatry. 2025 Jun 23:1-3. doi: 10.1192/bjp.2025.
    PubMed    
    
    
    
20. ANDREU-BERNABEU A, Gonzalez-Penas J, Mora A, Bernardo M, et al
    Linking prolonged childhood and adolescent loneliness to schizophrenia spectrum disorders: results from EU-GEI study.
    Br J Psychiatry. 2025 Jun 16:1-9. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
21. MUNOZ-CARACUEL M, Aleman-Morillo C, Garcia-San-Martin N, Garrido-Torres N, et al
    Predicting clinical and functional trajectories in individuals with first-episode psychosis by baseline deviations in grey matter volume.
    Br J Psychiatry. 2025 Jun 16:1-9. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
22. WETZLER SR, Madora MJ
    Puerperal insanity: history of postpartum psychosis.
    Br J Psychiatry. 2025;226:426-427.
    PubMed    
    
    
    May 2025
23. WILKINSON H, Johns LC, Batchelor R, Lau-Zhu A, et al
    Cognitive behavioural therapy for sleep problems in psychosis: systematic review of effectiveness and acceptability.
    Br J Psychiatry. 2025 May 22:1-16. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
24. O'HARE K, Lang U, Healy C, Kougianou I, et al
    Psychosis and bipolar disorder risk in child and adolescent mental health services in the UK: population cohort study.
    Br J Psychiatry. 2025 May 14:1-7. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
25. MUSTONEN A, Taipale H, Denissoff A, Ellila V, et al
    Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis.
    Br J Psychiatry. 2025 May 6:1-7. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
26. SHAJU A, Mishra A, Mohapatra D, Srinivasan A, et al
    Efficacy and safety of cholinergic modulators in patients with schizophrenia: meta-analysis of randomised controlled trials.
    Br J Psychiatry. 2025 May 2:1-11. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    April 2025
27. MONCRIEFF J, Pillai E, Marston L, Lewis G, et al
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders.
    Br J Psychiatry. 2025 Apr 14:1-7. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
28. LYMAN M, Fanshawe JB, Brewin J, Fanshawe TR, et al
    Introduction of point-of-care blood testing in early intervention in psychosis services: effects on physical health screening.
    Br J Psychiatry. 2025 Apr 11:1-6. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    March 2025
29. COWMAN M, Hodgekins J, Griffiths SL, Frawley E, et al
    Cognitive and clinical profiles in first-episode psychosis and their relationship with functional outcomes.
    Br J Psychiatry. 2025 Mar 26:1-8. doi: 10.1192/bjp.2025.
    PubMed     Abstract available
    
    
    
30. WHITING D, Glogowska M, Mallett S, Maughan D, et al
    Use of a violence risk prediction tool (Oxford Mental Illness and Violence) in early intervention in psychosis services: mixed methods study of acceptability, feasibility and clinical role.
    Br J Psychiatry. 2025 Mar 20:1-10. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    February 2025
31. LAGERBERG T, Lambe S, Paulino A, Yu R, et al
    Systematic review of risk factors for violence in psychosis: 10-year update.
    Br J Psychiatry. 2025;226:100-107.
    PubMed     Abstract available
    
    
    
32. ZANCHETA SB, de Alencar Quirino AH, Gomes SP, Nogueira GN, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study: commentary, Zancheta et al.
    Br J Psychiatry. 2025;226:114-115.
    PubMed    
    
    
    January 2025
33. KANG S, Yang JS, Yun BH, Gelaye B, et al
    Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study.
    Br J Psychiatry. 2025 Jan 10:1-8. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
34. WANG F, Liu Z, Wang J, Li X, et al
    Aberrant controllability of functional connectome during working memory tasks in patients with schizophrenia and unaffected siblings.
    Br J Psychiatry. 2025 Jan 7:1-10. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
35. FERNANDEZ-EGEA E, McCutcheon RA
    Clozapine monitoring requirements: is it time for an update?
    Br J Psychiatry. 2025;226:1-3.
    PubMed     Abstract available
    
    
    December 2024
36. ZHOU J, Millier A, Aballea S, Francois C, et al
    Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model.
    Br J Psychiatry. 2024 Dec 26:1-8. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
37. SMITH KA, Boyce N, Chevance A, Chiocchia V, et al
    Triangulating evidence from the GALENOS living systematic review on trace amine-associated receptor 1 (TAAR1) agonists in psychosis.
    Br J Psychiatry. 2024 Dec 23:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
38. NAUGHTON S, McGinty G, Duffy N, Marshall D, et al
    Intervening early across the lifespan: going beyond youth-focused psychosis care to meet the needs of women.
    Br J Psychiatry. 2024 Dec 4:1-3. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
39. YANG LH, Grivel MM, Blasco D, Girgis RR, et al
    Parsing stigma's relationship with the psychosocial functioning of youth identified as at clinical high risk for psychosis: evaluating whether symptom stigma or labelling stigma is stronger.
    Br J Psychiatry. 2024 Dec 4:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
40. CHESNEY E, Reilly TJ, Scott F, Slimani I, et al
    Psychosis associated with cannabis withdrawal: systematic review and case series.
    Br J Psychiatry. 2024 Dec 3:1-12. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    November 2024
41. GREENWOOD K, Jones C, Yaziji N, Healey A, et al
    The Early Youth Engagement (EYE-2) intervention in first-episode psychosis services: pragmatic cluster randomised controlled trial and cost-effectiveness evaluation.
    Br J Psychiatry. 2024 Nov 25:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
42. TREUR JL, Thijssen AB, Smit DJA, Tadros R, et al
    Associations of schizophrenia with arrhythmic disorders and electrocardiogram traits: genetic exploration of population samples.
    Br J Psychiatry. 2024 Nov 8:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
43. HALL J
    Schizophrenia - new treatments soon.
    Br J Psychiatry. 2024 Nov 8:1-2. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
44. TESLI N, Vaskinn A
    Violence and schizophrenia: let us take a deep breath and gain a meta-perspective.
    Br J Psychiatry. 2024;225:508-509.
    PubMed    
    
    
    October 2024
45. YANG JS, Kang S, Kim K, Tsai AC, et al
    Breast cancer risk among women with schizophrenia and association with duration of antipsychotic use: population-based cohort study in South Korea.
    Br J Psychiatry. 2024 Oct 31:1-7. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
46. NICHOLLS D, Budd J, Nunn P, French P, et al
    Investigating inequalities in patient outcomes for first-episode psychosis.
    Br J Psychiatry. 2024 Oct 10:1-7. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    September 2024
47. JIANG Y, Chang X, Feng J
    Towards a unified theory of the aetiology of schizophrenia.
    Br J Psychiatry. 2024 Sep 23:1-3. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
48. FERNANDEZ-EGEA E, Flanagan RJ, Taylor D, Gaughran F, et al
    Mortality associated with clozapine: what is the evidence?
    Br J Psychiatry. 2024;225:357-359.
    PubMed     Abstract available
    
    
    August 2024
49. LIU R, Li D, Ma Y, Tang L, et al
    Air pollutants, genetic susceptibility and the risk of schizophrenia: large prospective study.
    Br J Psychiatry. 2024 Aug 9:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
50. KIKUCHI Y, Kurosawa M, Sakata M, Takahashi Y, et al
    Effects of titration speed, gender, obesity and concomitant medications on the risk and onset time of clozapine-associated fever among Japanese patients with schizophrenia: retrospective review of charts from 21 hospitals.
    Br J Psychiatry. 2024 Aug 6:1-7. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
51. FAROOQ S, Hattle M, Kingstone T, Ajnakina O, et al
    Development and initial evaluation of a clinical prediction model for risk of treatment resistance in first-episode psychosis: Schizophrenia Prediction of Resistance to Treatment (SPIRIT).
    Br J Psychiatry. 2024 Aug 5:1-10. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
52. SHERGILL SS, Meshreky KM
    Towards a unified theory of the aetiology of schizophrenia: commentary, Shergill et al.
    Br J Psychiatry. 2024 Aug 5:1-2. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    
53. KUMARI V
    Towards a unified theory of the aetiology of schizophrenia: commentary, Kumari.
    Br J Psychiatry. 2024;225:341-342.
    PubMed    
    
    
    July 2024
54. HUANG ML, Wei LC
    Psychological framework to understand interpersonal violence by forensic patients with psychosis: commentary, Huang & Wei.
    Br J Psychiatry. 2024 Jul 31:1. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    May 2024
55. CHEN PH, Tsai SY, Chen PY, Pan CH, et al
    Lipid-modifying agents and risk of all-cause, natural and suicide mortality in schizophrenia: nationwide cohort study.
    Br J Psychiatry. 2024 May 16:1-9. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    
56. FREEMAN D
    Developing psychological treatments for psychosis.
    Br J Psychiatry. 2024;224:147-149.
    PubMed     Abstract available
    
    
    
57. FERNANDEZ-EGEA E, Chen S, Sanguesa E, Gasso P, et al
    The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.
    Br J Psychiatry. 2024;224:164-169.
    PubMed     Abstract available
    
    
    April 2024
58. QI R, Qureshi M, Gire N, Chaudhry IB, et al
    Ethnic density and first episode psychosis in the British Pakistani population: findings from the East Lancashire Early Intervention Service.
    Br J Psychiatry. 2024 Apr 18:1-6. doi: 10.1192/bjp.2024.
    PubMed     Abstract available
    
    
    March 2024
59. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium - CORRIGENDUM.
    Br J Psychiatry. 2024 Mar 18:1. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    February 2024
60. HASSIOTIS A, Noor M, Bebbington P, Ali A, et al
    Borderline intellectual functioning and psychosis: Adult Psychiatric Morbidity Survey evidence - CORRIGENDUM.
    Br J Psychiatry. 2024 Feb 13:1. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    January 2024
61. MCCUTCHEON RA, Cannon A, Parmer S, Howes OD, et al
    How to classify antipsychotics: time to ditch dichotomies?
    Br J Psychiatry. 2024;224:20-25.
    PubMed     Abstract available
    
    
    November 2023
62. SAHIN D, Kambeitz-Ilankovic L, Wood S, Dwyer D, et al
    Algorithmic fairness in precision psychiatry: analysis of prediction models in individuals at clinical high risk for psychosis.
    Br J Psychiatry. 2023 Nov 8:1-11. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    October 2023
63. LAMBE S, Cooper K, Fazel S, Freeman D, et al
    Psychological framework to understand interpersonal violence by forensic patients with psychosis.
    Br J Psychiatry. 2023 Oct 20:1-8. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    
64. KOHLER-FORSBERG O, Ge F, Hauksdottir A, Thordardottir EB, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study.
    Br J Psychiatry. 2023 Oct 18:1-7. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    
65. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium.
    Br J Psychiatry. 2023;223:485-492.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.